News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Resolves U.S. Shortage Of Tamiflu For Children


1/17/2014 6:55:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A temporary shortage in the United States of one of the leading flu medicines used to treat children with the sometimes deadly virus has been resolved, Roche, the maker of Tamiflu, said on Thursday. Due to high demand and packaging delays, Roche had experienced a shortage of supplies of the liquid version of the medicine, known a Tamiflu Oral Suspension, used to treat children under the age of 13 and adults unable to swallow pills. "We now anticipate having sufficient supply of both the liquid and capsule forms of Tamiflu to meet demand for this flu season," Roche spokeswoman Tara Iannuccillo said in an emailed statement.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Huffington Post
Read at News Release

comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES